Related Experiment Video
Updated: May 14, 2026

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
Published on: May 23, 2025
Distant metastases in meningioma: an underestimated problem
Alexey Surov1, Sebastian Gottschling, Julia Bolz
1Department of Radiology, Martin-Luther-university Halle-Wittenberg, Ernst-Grube Str. 40, 06097 Halle, Germany. alex.surow@medizin.uni-halle.de
Abstract:
Meningioma is a common intracranial neoplasm derived from meningothelial cells. Meningiomas are associated with a benign clinical course. However, malignant behaviour such as metastatic disease has been also described. Our aim was to analyze the metastatic pattern taking tumor grading into consideration, and to determine clinical signs of distant metastases in meningiomas. In this systematic review PubMed database was screened for distant meningioma metastases from 1990 to 2012. 95 articles were identified. Only cases with metastasized meningiomas were included in the analysis. Our analysis comprised 115 cases with 164 metastatic lesions. Primary tumors were in 33.9 % grade 1, 20.9 % grade 2, and 40 % grade 3. In 5.2 % the grade was not reported. In 93 % meningiomas were diagnosed and resected before distant metastases occurred. In 6.1 % metastases were identified simultaneously with primary tumors and in 0.9 % metastases were identified before the primary tumor was found. The metastatic lesions were localized most frequently in the lung (37.2 %), bones (16.5 %), intraspinally (15.2 %), and in the liver (9.2 %). Other locations were rarer. The size of the metastases varied from 0.6 to 28 cm (median size, 3 cm). There were no significant differences between sizes of the identified metastases in relation to tumor grading. 50.4 % of distant metastases were clinically manifest and 31.3 % were identified incidentally. In 18.3 % clinical signs were missing. In our review 31.3 % of metastatic meningiomas were found to be clinically silent. The prevalence of metastases in meningioma may be underreported.
Insights
Meningiomas, typically benign, can metastasize, most commonly to the lungs and bones. A significant portion of metastatic meningiomas are clinically silent, suggesting underreporting of this rare occurrence.
Area of Science:
- Neuro-oncology
- Pathology
- Oncology
Background:
- Meningiomas are common intracranial tumors originating from meningothelial cells.
- While generally benign, malignant behavior including distant metastases can occur.
- Understanding metastatic patterns and clinical presentation is crucial for patient management.
Purpose of the Study:
- To analyze the metastatic pattern of meningiomas, considering tumor grade.
- To identify clinical signs associated with distant meningioma metastases.
- To assess the prevalence and characteristics of metastatic meningioma cases.
Main Methods:
- Systematic review of PubMed database for distant meningioma metastases (1990-2012).
- Inclusion of 115 cases with 164 metastatic lesions.
- Analysis of tumor grade, metastatic site, size, and clinical presentation.
Main Results:
- Metastases were most frequent in the lung (37.2%), bones (16.5%), and intraspinally (15.2%).
- Tumor grade distribution: 33.9% grade 1, 20.9% grade 2, 40% grade 3.
- 50.4% of metastases were clinically manifest, 31.3% incidental, and 18.3% asymptomatic; 31.3% were clinically silent.
Conclusions:
- Meningioma metastasis, though rare, occurs and predominantly affects the lungs and bones.
- A substantial proportion of metastatic meningiomas are clinically silent, potentially leading to underdiagnosis.
- Metastatic patterns do not significantly differ by tumor grade, but higher grades are more common in metastatic cases.
More Related Videos
07:42Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection
Published on: January 16, 2026
06:44Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020